ORKA compared with JBIO: revenue, margins and what each company keeps, and the suppliers and customers both name

ORKAOruka Therapeutics, Inc.

Mkt capRevenueRevenue

JBIOJade Biosciences, Inc.

Mkt capRevenueRevenue

Compare

ORKAOruka Therapeutics, Inc.

JBIOJade Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ORKA

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.7%▲+6.40%×0.44

Q1 FY26±11.0%▼−8.52%×0.77

Sep 6 '24—▲+2.80%—

Aug 2 '24—▲+5.07%—

JBIO

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±18.9%▼−1.05%×0.06

May 8 '26±24.6%▲+6.56%×0.27

= impliedORKA realized, solidJBIO realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedspan: ORKA 738d · JBIO 217dSource: market data

Q1 FY26

±29.2%

▲+1.22%

×0.04

Jan 5 '26±26.0%▼−7.34%×0.28

ORKAOruka Therapeutics, Inc.

96.24▼−0.42%· post 98.76

Mkt cap$6.4B

JBIOJade Biosciences, Inc.

14.07▼−1.19%· post 14.07

ClosedOct 30 '26

Mkt cap$894.2M

Compare

ClosedOct 30 '26

ORKAOruka Therapeutics, Inc.

JBIOJade Biosciences, Inc.

96.24▼−0.42%post 98.76

Price

14.07▼−1.19%post 14.07

$6.4B

Mkt cap

$894.2M

ORKA96.24▼−0.42%vsJBIO14.07▼−1.19%ClosedOct 30 '26